Literature DB >> 15992799

Expression profile of an operationally-defined neural stem cell clone.

Mark A Parker1, Julia K Anderson, Deborah A Corliss, Victoria E Abraria, Richard L Sidman, Kook In Park, Yang D Teng, Douglas A Cotanche, Evan Y Snyder.   

Abstract

Neural stem cells (NSCs) are the most primordial and least committed cells of the nervous system, the cells that exist before regional specification develops. Because immunocytochemically-detectable markers that are sufficiently specific and sensitive to define an NSC have not yet been fully defined, we have taken the strong view that, to be termed a "stem cell" in the nervous system--in contrast to a "progenitor" or "precursor" (whose lineage commitment is further restricted)--a single neuroectodermally-derived cell must fulfill an operational definition that is essentially similar to that used in hematopoiesis. In other words, it must possess the following functional properties: (1) "Multipotency", i.e., the ability to yield mature cells in all three fundamental neural lineages throughout the nervous system--neurons (of all subtypes), astrocytes (of all types), oligodendrocytes--in multiple regional and developmental contexts and in a region and developmental stage-appropriate manner. (2) The ability to populate a developing region and/or repopulate an ablated or degenerated region of the nervous system with appropriate cell types. (3) The ability to be serially transplanted. (4) "Self-renewal", i.e., the ability to produce daughter cells (including new NSCs) with identical properties and potential. Having identified a murine neural cell clone that fulfills this strict operational definition--in contrast to other studies that used less rigorous or non-operational criteria for defining an NSC (e.g., the "neurosphere" assay)--we then examined, by comparing gene expression profiles, the relationship such a cell might have to (a) a multipotent somatic stem cell from another organ system (the hematopoietic stem cell [HSC]); (b) a pluripotent stem cell derived from the inner cell mass and hence without organ assignment (an embryonic stem cell); (c) neural cells isolated and maintained primarily as neurospheres but without having been subjected to the above mentioned operational screen ("CNS-derived neurospheres"). ESCs, HSCs, and operationally-defined NSCs--all of which have been identified not only by markers but by functional assays in their respective systems and whose state of differentiation could be synchronized--shared a large number of genes. Although, as expected, the most stem-like genes were expressed by ESCs, NSCs and HSCs shared a number of genes. CNS-derived neurospheres, on the other hand, expressed fewer "stem-like" genes held in common by the other operationally-defined stem cell populations. Rather they displayed a profile more consistent with differentiated neural cells. (Genes of neural identity were shared with the NSC clone.) Interestingly, when the operationally-defined NSC clone was cultured as a neurosphere (rather than in monolayer), its expression pattern shifted from a "stem-like" pattern towards a more "differentiated" one, suggesting that the neurosphere, without functional validation, may be a poor model for predicting stem cell attributes because it consists of heterogeneous populations of cells, only a small proportion of which are truly "stem-like". Furthermore, when operational definitions are employed, a common set of stem-like genes does emerge across both embryonic and somatic stem cells of various organ systems, including the nervous system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15992799     DOI: 10.1016/j.expneurol.2005.04.018

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  35 in total

1.  Targeting the enhancer of zeste homologue 2 in medulloblastoma.

Authors:  Irina Alimova; Sujatha Venkataraman; Peter Harris; Victor E Marquez; Paul A Northcott; Adrian Dubuc; Michael D Taylor; Nicholas K Foreman; Rajeev Vibhakar
Journal:  Int J Cancer       Date:  2012-07-30       Impact factor: 7.396

2.  Auditory hair cell explant co-cultures promote the differentiation of stem cells into bipolar neurons.

Authors:  B Coleman; J B Fallon; L N Pettingill; M G de Silva; R K Shepherd
Journal:  Exp Cell Res       Date:  2006-10-24       Impact factor: 3.905

3.  Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors.

Authors:  Sara Gil-Perotin; Mireya Marin-Husstege; Jiadong Li; Mario Soriano-Navarro; Frederique Zindy; Martine F Roussel; Jose-Manuel Garcia-Verdugo; Patricia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

4.  Neural stem cells injected into the sound-damaged cochlea migrate throughout the cochlea and express markers of hair cells, supporting cells, and spiral ganglion cells.

Authors:  Mark A Parker; Deborah A Corliss; Brianna Gray; Julia K Anderson; Richard P Bobbin; Evan Y Snyder; Douglas A Cotanche
Journal:  Hear Res       Date:  2007-06-20       Impact factor: 3.208

5.  Discovery of a functional protein complex of netrin-4, laminin gamma1 chain, and integrin alpha6beta1 in mouse neural stem cells.

Authors:  Fernanda I Staquicini; Emmanuel Dias-Neto; Jianxue Li; Evan Y Snyder; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-04       Impact factor: 11.205

Review 6.  G-protein-coupled receptors in adult neurogenesis.

Authors:  Van A Doze; Dianne M Perez
Journal:  Pharmacol Rev       Date:  2012-05-18       Impact factor: 25.468

Review 7.  Genetic and pharmacological intervention for treatment/prevention of hearing loss.

Authors:  Douglas A Cotanche
Journal:  J Commun Disord       Date:  2008-03-25       Impact factor: 2.288

Review 8.  Important precautions when deriving patient-specific neural elements from pluripotent cells.

Authors:  Xuejun H Parsons; Yang D Teng; Evan Y Snyder
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

Review 9.  Applications of neural and mesenchymal stem cells in the treatment of gliomas.

Authors:  Thomas Kosztowski; Hasan A Zaidi; Alfredo Quiñones-Hinojosa
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

Review 10.  Human embryonic stem cells: a potential source of transplantable neural progenitor cells.

Authors:  Daniel J Guillaume; Su-Chun Zhang
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.